Related references
Note: Only part of the references are listed.The microRNA signatures: aberrantly expressed miRNAs in prostate cancer
N. Sharma et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
lncRNA RP5-916L7.2 correlates with advanced tumor stage, and promotes cells proliferation while inhibits cells apoptosis through targeting miR-328 and miR-939 in tongue squamous cell carcinoma
Yong Chen et al.
CLINICAL BIOCHEMISTRY (2019)
MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF
Hu Zhao et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
lncRNA LINC00460 promoted colorectal cancer cells metastasis via miR-939-5p sponging
Yueyan Zhang et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Upregulation of MicroRNA-21 promotes tumorigenesis of prostate cancer cells by targeting KLF5
Chen Guan et al.
CANCER BIOLOGY & THERAPY (2019)
MiR-515-5p acts as a tumor suppressor via targeting TRIP13 in prostate cancer
Xiyan Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Long non-coding RNA AGAP2-AS1 promotes the proliferation of glioma cells by sponging miR-15a/b-5p to upregulate the expression of HDGF and activating Wnt/β-catenin signaling pathway
Yonghui Zheng et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Hepatoma-Derived Growth Factor and DDX5 Promote Carcinogenesis and Progression of Endometrial Cancer by Activating β-Catenin
Chunhua Liu et al.
FRONTIERS IN ONCOLOGY (2019)
MicroRNA-384 is lowly expressed in human prostate cancer cells and has anti-tumor functions by acting on HOXB7
Zhiming Hong et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Immunomodulatory MicroRNAs in cancer: targeting immune checkpoints and the tumor microenvironment
Hany A. Omar et al.
FEBS JOURNAL (2019)
The role of microRNAs in prostate cancer migration, invasion, and metastasis
Shirin Golabi Aghdam et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
MicroRNA-107 inhibits proliferation of prostate cancer cells by targeting cyclin E1
X. Zhang et al.
NEOPLASMA (2019)
Long-term oral exposure to safe dose of bisphenol A in association with high-fat diet stimulate the prostatic lesions in a rodent model for prostate cancer
Camila H. Facina et al.
PROSTATE (2018)
MicroRNAs in prostate cancer: From function to biomarker discovery
Ahmed A. Moustafa et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2018)
Next Generation Sequencing of urine exfoliated cells: an approach of prostate cancer microRNAs research
Gabriella Guelfi et al.
SCIENTIFIC REPORTS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet et al.
EUROPEAN UROLOGY (2017)
Prevention of Prostate Cancer Morbidity and Mortality Primary Prevention and Early Detection
Michael J. Barry et al.
MEDICAL CLINICS OF NORTH AMERICA (2017)
被撤回的出版物: Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway (Retracted article. See vol. 21, 2022)
Jia-Xing Zhang et al.
MOLECULAR CANCER (2017)
Second-line therapy in patients with metastatic castration-resistant prostate cancer with progression after or under docetaxel: A systematic review of nine randomized controlled trials
Michiel H. F. Poorthuis et al.
SEMINARS IN ONCOLOGY (2017)
Expression of urinary miRNAs targeting NLRs inflammasomes in bladder cancer
Ettore Mearini et al.
ONCOTARGETS AND THERAPY (2017)
Hepatoma-derived growth factor functions as an unfavorable prognostic marker of human gliomas
Yang Yang et al.
ONCOLOGY LETTERS (2017)
Anti-cancer activity of dose-fractioned mPE plus /- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients
Pierpaolo Pastina et al.
JOURNAL OF THORACIC DISEASE (2017)
MicroRNAs in prostate cancer: Functional role as biomarkers
Rajnee Kanwal et al.
CANCER LETTERS (2017)
Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway
Jia-Xing Zhang et al.
MOLECULAR CANCER (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Hepatoma-derived growth factor: A survival-related protein in prostate oncogenesis and a potential target for vitamin K2
Aditya Shetty et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role
Giovanni Cochetti et al.
ONCOTARGETS AND THERAPY (2016)
MiR-939 promotes the proliferation of human ovarian cancer cells by repressing APC2 expression
Xiong Ying et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Stability Assessment of Candidate Reference Genes in Urine Sediment of Prostate Cancer Patients for miRNA Applications
Maria Giulia Egidi et al.
DISEASE MARKERS (2015)
Hepatoma-derived growth factor predicts unfavorable prognosis of epithelial ovarian cancer
Xue-jun Liu et al.
ONCOTARGETS AND THERAPY (2015)
Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer
Jiayan Lian et al.
ONCOTARGET (2015)
Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis
San-Cher Chen et al.
ONCOTARGET (2015)
Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC
Francesca Fornari et al.
PLOS ONE (2015)
High Nuclear Expression of HDGF Correlates with Disease Progression and Poor Prognosis in Human Endometrial Carcinoma
Lijing Wang et al.
DISEASE MARKERS (2014)
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent-Update 2013
Axel Heidenreich et al.
EUROPEAN UROLOGY (2014)
miRCancer: a microRNA-cancer association database constructed by text mining on literature
Boya Xie et al.
BIOINFORMATICS (2013)
Prognostic prediction following radical prostatectomy for prostate cancer using conventional as well as molecular biological approaches
Hideaki Miyake et al.
INTERNATIONAL JOURNAL OF UROLOGY (2013)
Glyoxalase 1-419C>A Variant Is Associated with Oxidative Stress: Implications in Prostate Cancer Progression
Cinzia Antognelli et al.
PLOS ONE (2013)
Role of glyoxalase I in the proliferation and apoptosis control of human LNCaP and PC3 prostate cancer cells
Cinzia Antognelli et al.
PROSTATE (2013)
Circulating microRNAs and Kallikreins before and after Radical Prostatectomy: Are They Really Prostate Cancer Markers?
Maria Giulia Egidi et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Various effects of hepatoma-derived growth factor on cell growth, migration and invasion of breast cancer and prostate cancer cells
Zhenying Guo et al.
ONCOLOGY REPORTS (2011)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
The diverse functions of MicroRNAs in animal development and disease
Wigard P. Kloosterman et al.
DEVELOPMENTAL CELL (2006)
Expression of hepatoma-derived growth factor is correlated watch lymph node metastasis and prognosis of gastric carcinoma
S Yamamoto et al.
CLINICAL CANCER RESEARCH (2006)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Share Paper
